Dechra Pharmaceuticals (DCHPF) Stock Price, News & Analysis

Company Overview

Dechra Pharmaceuticals plc is a UK-based global specialist in veterinary pharmaceuticals, trading on the London Stock Exchange and quoted in the United States on the OTC market under the symbol DCHPF. Founded in 1997 and headquartered in Northwich, Cheshire, the company focuses exclusively on the development, manufacture and marketing of products for veterinary use. Dechra serves both companion and food-producing animal markets through a portfolio of branded pharmaceuticals and specialty compounds.

The company’s product range spans key therapeutic areas including endocrinology, dermatology, ophthalmology, pain management and anti-infectives. Dechra develops and commercializes oral and injectable pharmaceuticals, topical formulations and vaccines, as well as ancillary products such as anaesthetics and nutritional supplements. Research and development efforts emphasize innovative therapies with a high degree of formulation expertise, supported by in-house manufacturing and quality control capabilities across multiple sites.

Dechra maintains a presence in more than 50 countries, operating through regional sales and distribution networks in Europe, North America, Australasia and selected emerging markets. The company has grown organically and by targeted acquisitions, bringing niche veterinary assets into its platform to enhance its specialty focus. Leadership is headed by Chief Executive Officer Bill Siggers, under whom Dechra continues to pursue a strategy of narrow-area expertise and tailored geographic expansion.

Key Stats

• Today's Range: $46.90 to $46.90
• 50-Day Range: $46.90 to $46.90
• 52-Week Range: $30.00 to $47.40
• Volume: N/A
• Average Volume: 1,687 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DCHPF Stock Analysis - Frequently Asked Questions

How have DCHPF shares performed this year?

Dechra Pharmaceuticals' stock was trading at $46.90 on January 1st, 2026. Since then, DCHPF shares have increased by 0.0% and is now trading at $46.90.

How do I buy shares of Dechra Pharmaceuticals?

Shares of DCHPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:DCHPF
• CIK: N/A
• Web: dechra.com
• Phone: 441606814730
• Fax: N/A
• Employees: 2,457
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A